From 3 to 5 June, in Paris, IBSA will participate in the IMCAS World Congress 2022, the most important international congress dedicated to aesthetic medicine. An opportunity to meet with leading experts and discuss the advances and innovations in dermatology, plastic surgery and anti-aging science.
With its unique expertise – well consolidated over time – IBSA is an important player in the sector, as well as one of the world leaders in the development of hyaluronic acid-based products. Through its innovative vision and its investments in Research and Development, IBSA exports the know-how and excellence of the Made in Italy to over 90 international markets.
Corporate
IBSA protagonist at IMCAS World Congress 2022
The three days of symposia, workshops and conferences will be an opportunity for a fruitful and constructive exchange of views on the issues of aesthetic medicine.
Within the IMCAS Global Market Summit, the congress also offers more economic-oriented opportunities, such as the World Tribune. Luca Crippa, CEO & Managing Director of IBSA Farmaceutici, will speak at the “Consumables roundtable” on the topic of injectables, while analysing the dermatology market together with other industry leaders, to discuss future acquisitions, innovations, strategies and investments.
With a range of hyaluronic acid-based products ideal both for face and body, IBSA plays a leading role in the field of aesthetic medicine, providing patients with its expertise with the aim to preserve, protect and celebrate people’s authentic beauty.
